NSTE ACS Routine Versus Selective Invasive Strategy Decision Tool

NSTE ACS Routine Versus Selective Invasive Strategy Decision Tool Explanation and Clinical Context This decision tool is designed for patients with non ST segment elevation acute coronary syndromes who are potential candidates for coronary revascularization. The tool combines the GRACE risk score with simple clinical variables to help clinicians decide between a routine invasive strategy and a selective invasive strategy, and to estimate the appropriate timing of coronary angiography. A routine invasive strategy means that coronary angiography is planned during the index hospitalization with intent to proceed to percutaneous coronary intervention or coronary artery bypass graft surgery when appropriate.

Randomized trials and meta analyses have shown that in patients with NSTE ACS a routine invasive strategy reduces recurrent myocardial infarction and recurrent ischemia compared with a selective invasive strategy, with the greatest benefit in higher risk patients who have elevated cardiac biomarkers or other high risk features. According to the 2025 guideline, patients with NSTE ACS who are at intermediate or high risk of ischemic events and who are suitable candidates for revascularization should undergo an invasive strategy during hospitalization to reduce major adverse cardiovascular events. Very high risk patients with refractory angina, hemodynamic or electrical instability, acute heart failure, or other unstable features should undergo immediate invasive management with urgent transfer to a PCI capable center when needed.

High risk patients, such as those with GRACE risk score at least one hundred forty, markedly elevated troponin, or dynamic ST segment changes, are reasonable candidates for early invasive coronary angiography within twenty four hours. Patients who are clinically stable and at lower risk, particularly those with normal biomarkers and lower GRACE risk scores, derive less benefit from a routine invasive approach. In this group, either a routine invasive or selective invasive strategy is acceptable.

A selective invasive approach relies on noninvasive risk stratification with stress imaging or coronary CT angiography to identify those who would benefit from invasive coronary angiography. When the clinical likelihood of true NSTE ACS is low and competing diagnoses are more probable, initial noninvasive testing is preferred; invasive angiography is then reserved for patients with high risk findings or recurrent ischemic symptoms. This tool does not replace clinical judgment.

Decisions should always consider contra indications to invasive procedures, bleeding risk, renal function, comorbidities, patient preferences, and local system capabilities. The output of this calculator should be integrated with bedside assessment, shared decision making, and multidisciplinary discussions when the best strategy is uncertain. Reference Rao SV, O Donoghue ML, Ruel M, and colleagues.

Twenty twenty five ACC AHA ACEP NAEMSP SCAI guideline for the management of patients with acute coronary syndromes. J Am Coll Cardiol. Twenty twenty five; eighty five: two thousand one hundred thirty five to two thousand two hundred thirty seven.